ICD-10 Coding for Hilar Lymphadenopathy(C34.9, C34.9U, C78.01)
Learn about the ICD-10 coding for hilar lymphadenopathy, including documentation requirements and common coding pitfalls.
Complete code families applicable to Hilar Lymphadenopathy
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| R59.0 | Localized enlarged lymph nodes | Use when hilar lymphadenopathy is localized without systemic involvement. |
|
| D86.1 | Sarcoidosis of lung | Use when sarcoidosis is confirmed and involves the lungs. |
|
| C78.01 | Secondary malignant neoplasm of right lung | Use when metastasis to right hilar lymph nodes is confirmed. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutHilar Lymphadenopathy
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Hilar Lymphadenopathy.
Using R59.9 for unspecified lymphadenopathy.
Impact
Clinical: May lead to misinterpretation of clinical severity., Regulatory: Non-compliance with specificity requirements., Financial: Potential denial of claims due to lack of specificity.
Mitigation
Ensure documentation specifies location and extent., Use imaging to confirm diagnosis.
Coding R59.0 without specifying 'localized'.
Impact
Reimbursement: Potential underpayment due to incorrect coding., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate clinical data representation.
Mitigation
Ensure documentation specifies 'localized' hilar lymphadenopathy.
Lack of specificity in lymphadenopathy coding
Impact
Audits may target cases where lymphadenopathy is not clearly documented as localized or generalized.
Mitigation
Ensure all documentation includes specific location and extent of lymphadenopathy.